The effectiveness and efficiency of diabetes screening in Ontario, Canada: A population-based cohort study

BMC Public Health

Volumn 10, Issue , 2010, Pages

  Wilson, Sarah E ^a,b   Rosella, Laura C ^a,b   Lipscombe, Lorraine L ^a,c,d   Manuel, Douglas G ^a,b,e,f  

^a INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c WOMEN S COLLEGE HOSPITAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^f STATISTICS CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANADA; COHORT ANALYSIS; DIABETES MELLITUS; FEMALE; HEALTH CARE QUALITY; HEALTH SURVEY; HUMAN; MALE; MASS SCREENING; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; STANDARD; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; DIABETES MELLITUS; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; ONTARIO; PROGRAM EVALUATION; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 77955701826     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-10-506     Document Type: Article

References (33)

1. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. H King RE Aubert WH Herman, Diabetes Care 1998 21 1414 31 10.2337/diacare.21.9.1414 9727886
2. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. S Wild G Roglic A Green R Sicree H King, Diabetes Care 2004 27 1047 53 10.2337/diacare.27.5.1047 15111519
3. Global and societal implications of the diabetes epidemic. P Zimmet KG Alberti J Shaw, Nature 2001 414 782 787 10.1038/414782a 11742409
4. Prevalence of Diabetes and Impaired Fasting Glucose in Adults in the US Population. National Health and Nutrition Examination Survey 1999-2002. CC Cowie KF Rust DD Byrd-Holt MS Eberhardt KM Flegal MM Engelgau SH Saydah DE Williams LS Geiss EW Gregg, Diabetes Care 2006 29 1263 1268 10.2337/dc06-0062 16732006
5. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. MI Harris KM Flegal CC Cowie MS Eberhardt DE Goldstein RR Little HM Wiedmeyer DD Byrd-Holt, Diabetes Care 1998 21 518 24 10.2337/diacare.21.4.518 9571335
6. Department of Health, Health Survey for England 2003. Volume 1: Cardiovascular disease http://www.dh.gov.uk/en/Publicationsandstatistics/ Publications/PublicationsStatistics/DH-4098712 Accessed March 20, 2009
7. The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study. DW Dunstan PZ Zimmet TA Welborn MP De Courten AJ Cameron RA Sicree T Dwyer S Colagiuri D Jolley M Knuiman R Atkins JE Shaw, Diabetes Care 2002 25 829 34 10.2337/diacare.25.5.829 11978676
8. High prevalence of undiagnosed diabetes mellitus in Southern Germany: target populations for efficient screening. The KORA survey 2000. W Rathmann B Haastert A Icks H Löwel C Meisinger R Holle G Giani, Diabetologia 2003 46 182 9 12627316
9. Secular trends in the prevalence of diabetes and impaired glucose tolerance in urban South India - the Chennai Urban Rural Epidemiology Study [CURES-17]. V Mohan M Deepa R Deepa CS Shanthirani S Farooq A Ganesan M Datta, Diabetologia 2006 49 1175 8 10.1007/s00125-006-0219-2 16570158
10. Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. MI Harris R Klein TA Welborn MW Knuiman, Diabetes Care 1992 15 815 819 10.2337/diacare.15.7.815 1516497
11. Prevalence of retinopathy in people with diabetes, impaired glucose tolerance and normal glucose tolerance. U Rajala M Laakso Q Qiao S Keinanen-Kiukaanniemi, Diabetes Care 1998 21 1664 1669 10.2337/diacare.21.10. 1664 9773727 (Pubitemid 28449804)
12. Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes [UKPDS 61]? S Colagiuri CA Cull RR Holman, Diabetes Care 2002 25 1410 1417 10.2337/diacare.25.8.1410 12145243
13. Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis. CL Gillies PC Lambert KR Abrams AJ Sutton NJ Cooper RT Hsu MJ Davies K Khunti, BMJ 2008 336 1180 5 10.1136/bmj.39545. 585289.25 18426840
14. Screening for type 2 diabetes: literature review and economic modeling. N Waugh G Scotland P McNamee M Gillett A Brennan E Goyder R Williams A John, Health Techol Assess 2007 11 1 125
15. 1998 clinical practice guidelines for the management of diabetes in Canada. S Meltzer L Lawrence D Daneman HC Gerstein D Lau S Ludwig J-F Yale B Zinman D Lillie Steering and Expert Committees, CMAJ 1998 Suppl 1 29 9834731
16. Canadian Diabetes Association 2003 clinical practice guidelines for the prevention and management of diabetes in Canada. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee, Can J Diabetes 2003 27 10 S13
17. Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee, Can J Diabetes 2008 32 1 S201
18. Screening for type 2 diabetes mellitus to prevent vascular complications: updated recommendations from the Canadian Task Force on Preventive Health Care. DS Feig VA Palda L Lipscombe the Canadian Task Force on Preventive Health Care, CMAJ 2005 172 177 80 15655234
19. Trends in laboratory testing for diabetes in Ontario, Canada 1995-2005: A population-based study. SE Wilson LL Lipscombe LC Rosella DG Manuel, BMC Health Services Research 2009 9 41 47 10.1186/1472-6963-9-41 19250533
20. Statistics Canada, Canadian Community Health Survey http://www.statcan. gc.ca/cgi-bin/imdb/p2SV.pl?Function=getSurvey&SDDS=3226&lang=en&db= imdb&adm=8&dis=2 Accessed 3 August 2010
21. Ontario Ministry of Finance, 2006 Census Based Population Estimates http://www.fin.gov.on.ca/english/economy/demographics/estimates06/factsheet1. html Accessed 22 March 2009
22. Statistics Canada. Labour Force Survey, http://www.statcan.gc.ca/cgi-bin/ imdb/p2SV.pl?Function=getSurvey&SDDS=3701&lang=en&db=imdb&adm= 8&dis=2 Accessed 12 May 2010
23. Diabetes in Ontario. Determination of prevalence and incidence using a validated administrative data algorithm. JE Hux F Ivis V Flintoft A Bica, Diabetes Care 2002 25 512 516 10.2337/diacare.25.3.512 11874939
24. Trends in diabetes prevalence, incidence and mortality in Ontario, Canada 1995-2005: a population-based study. L Lipscombe JE Hux, Lancet 2007 369 750 756 10.1016/S0140-6736(07)60361-4 17336651
25. A population-based risk algorithm for the development of physician-diagnosed diabetes mellitus (DM). LC Rosella D Manuel, Am J Epidemiol 2006 163 Suppl S 182 S182
26. A population based risk algorithm for the development of diabetes: Development and validation of the Diabetes Population Risk Tool (DPoRT). DG Manuel C Burchill TA Stukel, J Epidemiol Community Health 2010 20515896
27. Ontario Ministry of Health and Long Term Care, Schedule of Laboratory Fees, Preamble http://www.health.gov.on.ca/english/providers/program/ohip/sob/ lab/lab-mn.html Accessed March 28, 2007
28. Gender-releated differences in the association between socioeconomic status and self-reported diabetes. M Tang Y Chen D Krewski, Int J Epidemiol 2003 32 381 385 10.1093/ije/dyg075 12777423
29. Opportunistic Screening for Diabetes in Routine Clinical Practice. MW Ealovega BP Tabaei M Brandle R Burke WH Herman, Diabetes Care 2004 27 9 12 10.2337/diacare.27.1.9 14693958
30. Characteristics of undiagnosed diabetes mellitus in a population undergoing health screening in Japan: target populations for efficient screening. Y Bando H Kanehara K Aoki K Katoh D Toya N Tanaka, Diabetes Res Clin Pract 2009 83 341 6 10.1016/j.diabres.2008.11.033 19118911
31. Number needed to screen: development of a statistic for disease screening. CM Rembold, BMJ 1998 317 307 12 9685274
32. Public Health Surveillance of Diabetes in the United States. J Desai L Geiss Q Mukhtar T Harwell S Benjamin R Bell E Tierney, J Public Health Management Practice 2003 November 44 S51
33. New York City Department of Health and Mental Hygiene, The New York City A1C Registry http://www.nyc.gov/html/doh/html/diabetes/diabetes-nycar.shtml Accessed March 20, 2009